论文部分内容阅读
目的观察血必净注射液治疗弥散性血管内凝血(DIC)的临床疗效。方法:将62例符合DIC患者随机分为治疗组与对照组各31例。两组均采用治疗原发病、抗感染、低分子肝素、补充新鲜血浆等常规治疗。治疗组在常规治疗的基础上加用血必净注射液治疗。监测两组患者入院后治疗第10天凝血酶原时间(PT)、活化部分凝血酶原时间(APTT)、凝血酶时间(TT)、纤维蛋白原定量(FIB)、D二聚体定量的动态变化。结果:治疗组治疗后凝血指标改善明显优于对照组,两组比较有显著性差异(P<0.05),治疗组总有效率为77.42%明显高于对照组38.71%,两组比较有显著性差异(P<0.05)。结论:在常规治疗的基础上应用血必净注射液治疗DIC效果显著。
Objective To observe the clinical efficacy of Xuebijing Injection in the treatment of disseminated intravascular coagulation (DIC). Methods: 62 patients with DIC were randomly divided into treatment group and control group, 31 cases each. Two groups were used to treat the primary disease, anti-infection, low molecular weight heparin, add fresh plasma and other conventional treatment. The treatment group was treated with Xuebijing injection on the basis of routine treatment. The dynamic changes of prothrombin time (PT), activated partial prothrombin time (APTT), thrombin time (TT), fibrinogen quantitation (FIB) and D dimer concentration Variety. Results: The improvement of coagulation index in the treatment group was obviously better than that in the control group (P <0.05). The total effective rate in the treatment group was 77.42%, significantly higher than that in the control group (38.71%). There was significant difference between the two groups Difference (P <0.05). Conclusion: The treatment of DIC with Xuebijing injection on the basis of routine treatment has a significant effect.